These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12939872

  • 1. [Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs].
    Mishin VIu, Vasil'eva IA, Makieva VG, Kuz'mina NV, Prikazchikova AV, Khoroshutina VV.
    Probl Tuberk Bolezn Legk; 2003; (7):24-9. PubMed ID: 12939872
    [Abstract] [Full Text] [Related]

  • 2. [Incidence and nature of adverse reactions to antitubercular drugs in children with primary intrathoracic tuberculosis].
    Kurmanova NK.
    Probl Tuberk; 1988; (6):33-6. PubMed ID: 2974988
    [No Abstract] [Full Text] [Related]

  • 3. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
    Shmelev EI, Stepanian IE.
    Probl Tuberk; 1996; (6):57-60. PubMed ID: 9019774
    [Abstract] [Full Text] [Related]

  • 4. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
    Chukanov VI, Kaminskaia GO, Livchane E.
    Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

  • 6. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].
    Ubaĭdullaev AM, Tashpulatova FK, Kazakov KS.
    Probl Tuberk; 1998 Jan; (4):23-4. PubMed ID: 9771032
    [Abstract] [Full Text] [Related]

  • 7. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C, Bercion R, Koulla-Shiro S.
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [Abstract] [Full Text] [Related]

  • 8. [Reamberin in tuberculosis chemotherapy and its effect on liver function].
    Antibiot Khimioter; 2013 Aug; 58(3-4):33-6. PubMed ID: 24640150
    [Abstract] [Full Text] [Related]

  • 9. [Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
    Kazakov KS, Zakharova RI, Absadykova FT.
    Probl Tuberk; 1990 Aug; (9):40-2. PubMed ID: 2274509
    [Abstract] [Full Text] [Related]

  • 10. [Toxicity in the current treatment of pulmonary tuberculosis in children].
    Altet Gómez MN, Alcáide Megías J, Boque Genovard MA.
    An Esp Pediatr; 1984 Jan; 20(1):18-27. PubMed ID: 6230974
    [Abstract] [Full Text] [Related]

  • 11. [THE FREQUENCY OF ADVERSE REACTIONS TO ANTITUBERCULOUS AGENTS IN FIRST DETECTED PATIENTS OLDER THAN 18 YEARS WITH PULMONARY TUBERCULOSIS AND THE FACTORS INFLUENCING THEIR DEVELOPMENT].
    Tuberk Biolezni Legkih; 2010 Jan; (2):44-8. PubMed ID: 27529943
    [Abstract] [Full Text] [Related]

  • 12. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV, Ovsiankina ES.
    Probl Tuberk; 2003 Jan; (1):28-30. PubMed ID: 12652980
    [Abstract] [Full Text] [Related]

  • 13. [Use of a mathematic method of prognosis in adverse reactions to chemotherapy of tuberculosis].
    Kazakov KS, Kozarev MI.
    Probl Tuberk; 1987 Jan; (2):43-5. PubMed ID: 3575279
    [No Abstract] [Full Text] [Related]

  • 14. Adverse drug reactions and outcome of short course anti-tuberculosis drugs between single daily dose and split drug dose (BID) in pulmonary tuberculosis.
    Chuchottaworn C, Saipan B, Kittisup C, Cheewakul K.
    J Med Assoc Thai; 2012 Aug; 95 Suppl 8():S1-5. PubMed ID: 23130467
    [Abstract] [Full Text] [Related]

  • 15. [Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].
    Karachunskiĭ MA, Kaminskaia GO, Uvarova TE.
    Probl Tuberk Bolezn Legk; 2004 Aug; (9):25-8. PubMed ID: 15532463
    [Abstract] [Full Text] [Related]

  • 16. [Side effects of chemotherapy in patients with pulmonary tuberculosis and concomitant diseases].
    Nikolaeva OD.
    Lik Sprava; 2003 Aug; (3-4):74-8. PubMed ID: 12889365
    [Abstract] [Full Text] [Related]

  • 17. [Results of the treatment of patients with pulmonary tuberculosis by the short-term chemotherapy method with reference to the side effects of the drugs].
    Westfal I, Spychalski W, Szelerska-Twardosz H, Grzegorzewska A, Ryszewski W.
    Pneumonol Pol; 1988 Apr; 56(4):163-5. PubMed ID: 3412967
    [No Abstract] [Full Text] [Related]

  • 18. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
    Cheng SQ.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
    [No Abstract] [Full Text] [Related]

  • 19. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK, Dzodzuashvili KA.
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract] [Full Text] [Related]

  • 20. [Adverse reactions of antituberculous drugs].
    Hagiwara T, Morita Y, Yamaguchi H, Ishikawa H, Ueda S, Horie T, Okayasu M.
    Kekkaku; 1988 Dec; 63(12):763-71. PubMed ID: 3226031
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.